Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vascular Surgery
  Free Subscription

Articles published in
J Am Coll Cardiol
    April 2024
  1. SIBBING D
    Modulation of Antiplatelet Therapy in PCI-Treated Patients: A Rocky Road Toward More Individualized Treatment.
    J Am Coll Cardiol. 2024;83:1382-1385.
    >> Share

  2. THOMAS CD, Franchi F, Rossi JS, Keeley EC, et al
    Effectiveness of Clopidogrel vs Alternative P2Y(12) Inhibitors Based on the ABCD-GENE Score.
    J Am Coll Cardiol. 2024;83:1370-1381.
    >> Share

  3. SCHNEIDER PA, Olin JW
    Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
    J Am Coll Cardiol. 2024;83:1222-1224.
    >> Share

  4. WARGNY M, Leux C, Chatellier G, Coudol S, et al
    Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease.
    J Am Coll Cardiol. 2024;83:1207-1221.
    >> Share

    March 2024
  5. ZIERATH R, Shah AM
    Reply: Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
    J Am Coll Cardiol. 2024;83:e119.
    >> Share

  6. MURAKAMI T
    Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
    J Am Coll Cardiol. 2024;83:e117.
    >> Share

  7. BATCHELOR WB, Damluji AA
    Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
    J Am Coll Cardiol. 2024;83:1082-1084.
    >> Share

  8. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
    Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:1073-1081.
    >> Share

  9. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
    Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024;83:1059-1069.
    >> Share

  10. SCHWANN TA, Engelman DT
    Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
    J Am Coll Cardiol. 2024;83:929-931.
    >> Share

  11. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
    Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2024;83:918-928.
    >> Share

  12. MUKHERJEE D
    Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
    J Am Coll Cardiol. 2024;83:901-903.
    >> Share

  13. LEE JM, Kim H, Park YS, Jo HH, et al
    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:890-900.
    >> Share

    February 2024
  14. KIM YY, Hoteit MA
    Turning to "Omics" in Understanding Fontan-Associated Liver Disease.
    J Am Coll Cardiol. 2024;83:739-740.
    >> Share

  15. BRAVO-JAIMES K, Wu X, Reardon LC, Lluri G, et al
    Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation.
    J Am Coll Cardiol. 2024;83:726-738.
    >> Share

  16. DIMAIO JM, McCullough KA, Widmer RJ
    A Post Hoc Analysis of ISCHEMIA: Are All Events Created Equal?
    J Am Coll Cardiol. 2024;83:559-561.
    >> Share

    January 2024
  17. STONE GW, Ali ZA, Hochman JS, Maron DJ, et al
    REPLY: Interpreting the Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2024;83:e39-e40.
    >> Share

  18. GUYTON RA, Halkos ME
    Benefit of Complete Anatomic Revascularization in ISCHEMIA: Reprise of a Familiar Theme.
    J Am Coll Cardiol. 2024;83:e37.
    >> Share

  19. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Functional vs Anatomical Complete Revascularization: Is There an "ISCHEMIA" of FFR?
    J Am Coll Cardiol. 2024;83:e35.
    >> Share

  20. HIRUMA T, Kitamura M, Takamisawa I, Izumi Y, et al
    Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:546-548.
    >> Share

  21. CAPODANNO D, Spagnolo M
    Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI: Different Approaches, Similar Outcomes.
    J Am Coll Cardiol. 2024;83:414-416.
    >> Share

  22. BATES ER
    Clinically Significant Differences Between P2Y(12) Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated.
    J Am Coll Cardiol. 2024;83:e9-e10.
    >> Share

  23. TEHRANI BN, Batchelor WB, Spinosa D
    High-Risk Acute Pulmonary Embolism: Where Do We Go From Here?
    J Am Coll Cardiol. 2024;83:44-46.
    >> Share

  24. BELLEMAIN-APPAIX A, Montalescot G
    Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting.
    J Am Coll Cardiol. 2024;83:32-34.
    >> Share

    December 2023
  25. GRINES CL, DuPont A
    Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?
    J Am Coll Cardiol. 2023;82:2177-2178.
    >> Share

  26. KUNO T, Kiyohara Y, Maehara A, Ueyama HA, et al
    Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.
    J Am Coll Cardiol. 2023;82:2167-2176.
    >> Share

    November 2023
  27. PAI RG
    Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e215.
    >> Share

  28. KURLANSKY PA, Bittl JA
    Learning From Machines to Predict Mortality After Surgical or Percutaneous Revascularization.
    J Am Coll Cardiol. 2023;82:2125-2127.
    >> Share

  29. NINOMIYA K, Kageyama S, Shiomi H, Kotoku N, et al
    Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?
    J Am Coll Cardiol. 2023;82:2113-2124.
    >> Share

  30. WERESKI R, Chapman AR, Mills NL
    Reply: Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e217.
    >> Share

  31. BARRABES JA, Rodenas-Alesina E, Mila L
    Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:2031-2033.
    >> Share

  32. REDFORS B, Stone GW, Alexander JH, Bates ER, et al
    Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023 Nov 8:S0735-1097(23)07988.
    >> Share

    October 2023
  33. WATANABE H, Morimoto T, Natsuaki M, Yamamoto K, et al
    Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results.
    J Am Coll Cardiol. 2023 Oct 18:S0735-1097(23)07750.
    >> Share

  34. YANG S, Kang J, Park KW, Hur SH, et al
    Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks.
    J Am Coll Cardiol. 2023;82:1565-1578.
    >> Share

  35. ORTEGA-PAZ L, Sabate M, Angiolillo DJ
    Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
    J Am Coll Cardiol. 2023;82:1579-1582.
    >> Share

  36. KANG DY, Ahn JM, Yun SC, Hur SH, et al
    Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
    J Am Coll Cardiol. 2023 Oct 17:S0735-1097(23)07816.
    >> Share

  37. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    >> Share

    September 2023
  38. POLZL L, Engler C, Sterzinger P, Lohmann R, et al
    Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac Surgery.
    J Am Coll Cardiol. 2023;82:1301-1312.
    >> Share

  39. STONE GW, Ali ZA, O'Brien SM, Rhodes G, et al
    Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023;82:1175-1188.
    >> Share

  40. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
    Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;82:999-1010.
    >> Share

    August 2023
  41. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    >> Share

  42. MENDIETA G, Mehta S, Baber U, Angiolillo DJ, et al
    Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
    J Am Coll Cardiol. 2023;82:687-700.
    >> Share

  43. FANG J, Liu Y, Zhu Y, Li R, et al
    First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    J Am Coll Cardiol. 2023;82:575-586.
    >> Share

  44. LEE SJ, Joo JH, Park S, Kim C, et al
    Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2023;82:401-410.
    >> Share

    July 2023
  45. AHMAD Y, Velazquez EJ
    The Interplay of Complete Revascularization and Angina: More Is More?
    J Am Coll Cardiol. 2023;82:314-316.
    >> Share

  46. CAO L, Zhang H, Ge Y, Guo W, et al
    Avoiding Stroke in Patients Undergoing Endovascular Aortic Arch Repair: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:265-277.
    >> Share

  47. GRAGNANO F, Cao D, Pirondini L, Franzone A, et al
    P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
    J Am Coll Cardiol. 2023;82:89-105.
    >> Share

  48. KUMBHANI DJ, de Lemos JA
    The Optimal Antiplatelet Agent for Secondary Prevention of Coronary Artery Disease: Ring Out the Old?
    J Am Coll Cardiol. 2023;82:106-108.
    >> Share

    June 2023
  49. GARTENBERG AJ, Krishnamurthy G, Srinivasan A, Escobar FA, et al
    Intrahepatic and Periduodenal Embolization for Protein-Losing Enteropathy Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2023;81:2476-2478.
    >> Share

  50. ABDULKARIM A, Shaji S, Elfituri M, Gunsaulus M, et al
    Pulmonary Complications in Patients With Fontan Circulation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2434-2444.
    >> Share

  51. DAUERMAN HL
    Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.
    J Am Coll Cardiol. 2023;81:2417-2419.
    >> Share

  52. RATHOD KS, Teoh Z, Tyrlis A, Choudry FA, et al
    Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.
    J Am Coll Cardiol. 2023;81:2406-2416.
    >> Share

  53. SIMARD T, Sarma D, Miranda WR, Jain CC, et al
    Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2361-2373.
    >> Share

  54. GRAGNANO F, Mehran R, Calabro P, Valgimigli M, et al
    Reply: DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e193.
    >> Share

  55. APOSTOLOS A, Vasilagkos G, Toutouzas K, Tsigkas G, et al
    DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e191.
    >> Share

  56. STOUT K, Buber J
    The Last Stage of the Fontan Operation?
    J Am Coll Cardiol. 2023;81:2172-2174.
    >> Share

  57. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    >> Share

  58. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2149-2160.
    >> Share

    May 2023
  59. STONE GW, Gaudino M
    Reconsidering the Direction of Coronary Revascularization Trials.
    J Am Coll Cardiol. 2023;81:1974-1978.
    >> Share

  60. KANJI R, Gue YX, Memtsas V, Spencer NH, et al
    Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;81:1918-1932.
    >> Share

  61. STONE GW, Kereiakes DJ, Gori T, Metzger DC, et al
    Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial.
    J Am Coll Cardiol. 2023 May 13:S0735-1097(23)05527.
    >> Share

    April 2023
  62. HAGER A
    Invasive Cardiopulmonary Exercise Testing in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:1601-1604.
    >> Share

    March 2023
  63. TRUESDELL AG, Mehta A, Cilia LA
    Myocardial Infarction, Cardiogenic Shock, and Cardiac Arrest: Management Made Simple, But Not Too Simple.
    J Am Coll Cardiol. 2023;81:1177-1180.
    >> Share

  64. ZEYMER U, Alushi B, Noc M, Mamas MA, et al
    Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:1165-1176.
    >> Share

    February 2023
  65. TU S, Xu B, Chen L, Hong H, et al
    Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain.
    J Am Coll Cardiol. 2023;81:756-767.
    >> Share

  66. FLATHER M, Talukder S
    Saphenous Vein Grafts for Coronary Surgery: More May Be Less.
    J Am Coll Cardiol. 2023;81:726-728.
    >> Share

  67. SHIH E, Squiers JJ, Banwait JK, Mack MJ, et al
    Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.
    J Am Coll Cardiol. 2023;81:713-725.
    >> Share

  68. TRUESDELL AG, Alasnag MA, Kaul P, Rab ST, et al
    Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:590-605.
    >> Share

  69. BHATT DL
    Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?
    J Am Coll Cardiol. 2023;81:553-556.
    >> Share

  70. GRAGNANO F, Mehran R, Branca M, Franzone A, et al
    P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2023;81:537-552.
    >> Share

  71. KERN KB
    Timely Reperfusion for Everyone...Except for Some Out-of-Hospital Cardiac Arrest Patients?
    J Am Coll Cardiol. 2023;81:457-459.
    >> Share

  72. SPIRITO A, Vaisnora L, Papadis A, Iacovelli F, et al
    Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:446-456.
    >> Share

    January 2023
  73. LIN J, Lluri G
    Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation.
    J Am Coll Cardiol. 2023;81:390-393.
    >> Share

  74. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    >> Share

  75. BONACA MP, Hogan SE
    Tradeoffs in Approach to PAD Revascularization: Shared Decision Making in the Spotlight.
    J Am Coll Cardiol. 2023;81:371-373.
    >> Share

  76. FARHAN S, Enzmann FK, Bjorkman P, Kamran H, et al
    Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease.
    J Am Coll Cardiol. 2023;81:358-370.
    >> Share

  77. FELDMAN DN, Klein AJP
    Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?
    J Am Coll Cardiol. 2023;81:250-252.
    >> Share

  78. SHISHEHBOR MH, Scheinert D, Jain A, Brodmann M, et al
    Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    J Am Coll Cardiol. 2023;81:237-249.
    >> Share

  79. DHAUN N, Pugh D, Youngstein T
    Percutaneous Intervention in Takayasu Arteritis: Potential Advantages of Procedural Perseverance.
    J Am Coll Cardiol. 2023;81:65-67.
    >> Share

  80. JOSEPH G, Thomson VS, Attumalil TV, Mathen PG, et al
    Outcomes of Percutaneous Intervention in Patients With Takayasu Arteritis.
    J Am Coll Cardiol. 2023;81:49-64.
    >> Share

    November 2022
  81. SONG L, Xu B, Tu S, Guan C, et al
    2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
    J Am Coll Cardiol. 2022;80:2089-2101.
    >> Share

  82. DAVIDSON LJ, Cleveland JC, Welt FG, Anwaruddin S, et al
    A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2119-2134.
    >> Share

  83. ROYSE A, Ren J, Royse C, Tian DH, et al
    Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1833-1843.
    >> Share

  84. TARDIF JC, Thorin E
    Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1815-1817.
    >> Share

  85. NICHOL G, West A
    Contemporary Approaches to Reducing Morbidity and Mortality in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1799-1801.
    >> Share

  86. GONG W, Yan Y, Wang X, Zheng W, et al
    Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1788-1798.
    >> Share

  87. KORJIAN S, Yeh RW, Cutlip DE
    Ischemic Risk Prediction Scores: Practice-Changing or Just Practice?
    J Am Coll Cardiol. 2022;80:1748-1750.
    >> Share

  88. BATRA G, Lindback J, Becker RC, Harrington RA, et al
    Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1735-1747.
    >> Share

    October 2022
  89. BOHME M, Desch S, Rosolowski M, Scholz M, et al
    Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1545-1556.
    >> Share

    September 2022
  90. JIN Z, Xu B, Yang X, Jia R, et al
    Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
    J Am Coll Cardiol. 2022;80:1254-1264.
    >> Share

  91. SATTAR Y, Aronow HD, Alam M
    Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line?
    J Am Coll Cardiol. 2022;80:1251-1253.
    >> Share

  92. KRISHNAN P, Farhan S, Schneider P, Kamran H, et al
    Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    J Am Coll Cardiol. 2022;80:1241-1250.
    >> Share

  93. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    >> Share

  94. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
    Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1220-1237.
    >> Share

    August 2022
  95. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
    Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
    J Am Coll Cardiol. 2022;80:887-897.
    >> Share

  96. STAHLI BE, Klingenberg R, Heg D, Branca M, et al
    Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)06613.
    >> Share

  97. OUZOUNIAN M, Tadros RO, Svensson LG, Lyden SP, et al
    Thoracoabdominal Aortic Disease and Repair: JACC Focus Seminar, Part 3.
    J Am Coll Cardiol. 2022;80:845-856.
    >> Share

  98. HENSLEY SE, Upchurch GR Jr
    Repair of Abdominal Aortic Aneurysms: JACC Focus Seminar, Part 1.
    J Am Coll Cardiol. 2022;80:821-831.
    >> Share

  99. VALGIMIGLI M, Frigoli E, Vranckx P, Ozaki Y, et al
    Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2022;80:766-778.
    >> Share

    July 2022
  100. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
    Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:348-372.
    >> Share

    June 2022
  101. EVANGELISTA A, Pineda V, Guala A, Bijnens B, et al
    False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection.
    J Am Coll Cardiol. 2022;79:2415-2427.
    >> Share

  102. VERDOIA M, Gioscia R, Rognoni A
    Updates on the Management of STEMI in 2021: Beyond COVID-19.
    J Am Coll Cardiol. 2022;79:2245-2246.
    >> Share

  103. GARCIA S, Dehghani P, Stanberry L, Grines C, et al
    Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
    J Am Coll Cardiol. 2022;79:2236-2244.
    >> Share

    May 2022
  104. RAJKUMAR CA, Wereski R, Parsonage W, Cullen L, et al
    Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2022;79:2185-2187.
    >> Share

  105. DORFMAN AL, Del Nido PJ
    The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
    J Am Coll Cardiol. 2022;79:1846-1848.
    >> Share

  106. KING G, Buratto E, Celermajer DS, Grigg L, et al
    Natural and Modified History of Atrioventricular Valve Regurgitation in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2022;79:1832-1845.
    >> Share

  107. SHERRID MV, Massera D, Swistel DG
    Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
    J Am Coll Cardiol. 2022;79:1656-1659.
    >> Share

  108. CUI H, Schaff HV, Wang S, Lahr BD, et al
    Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1647-1655.
    >> Share

    April 2022
  109. OLIN JW, Johnston-Cox H
    Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
    J Am Coll Cardiol. 2022;79:1489-1491.
    >> Share

  110. ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
    Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
    J Am Coll Cardiol. 2022;79:1477-1488.
    >> Share

  111. GRANGER CB, Krychtiuk KA, Gersh BJ
    Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
    J Am Coll Cardiol. 2022;79:1474-1476.
    >> Share

  112. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
    J Am Coll Cardiol. 2022;79:1458-1473.
    >> Share

  113. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
    Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
    J Am Coll Cardiol. 2022;79:1407-1425.
    >> Share

  114. MEHRAN R, Cao D, Vogel B
    Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
    J Am Coll Cardiol. 2022;79:1285-1287.
    >> Share

  115. KIM TO, Kang DY, Ahn JM, Kim SO, et al
    Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
    J Am Coll Cardiol. 2022;79:1270-1284.
    >> Share

    March 2022
  116. KWONG RY, Cardoso R, Jerosch-Herold M
    Quantitative CMR Perfusion in Patients After CABG: Emerging and Promising Evidence.
    J Am Coll Cardiol. 2022;79:1152-1154.
    >> Share

  117. WONG CCY, Yong ASC, Keech A, Ada C, et al
    Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
    J Am Coll Cardiol. 2022;79:1127-1128.
    >> Share

  118. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
    5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
    J Am Coll Cardiol. 2022;79:965-974.
    >> Share

    February 2022
  119. MCCARTHY CP, Januzzi JL Jr
    Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward.
    J Am Coll Cardiol. 2022;79:527-529.
    >> Share

  120. UEKI Y, Otsuka T, Bar S, Koskinas KC, et al
    Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
    J Am Coll Cardiol. 2022;79:513-526.
    >> Share

  121. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    >> Share

  122. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    >> Share

    January 2022
  123. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
    Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
    J Am Coll Cardiol. 2022;79:267-279.
    >> Share

  124. HAN Y, Liao Z, Li Y, Zhao X, et al
    Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
    J Am Coll Cardiol. 2022;79:116-128.
    >> Share

  125. LIU T, Howarth AG, Chen Y, Nair AR, et al
    Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.
    J Am Coll Cardiol. 2022;79:35-48.
    >> Share

    December 2021
  126. GRINES CL, Marshall JJ
    Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter!
    J Am Coll Cardiol. 2021;78:2561-2562.
    >> Share

  127. RATHOD KS, Comer K, Casey-Gillman O, Moore L, et al
    Early Hospital Discharge Following PCI for Patients With STEMI.
    J Am Coll Cardiol. 2021;78:2550-2560.
    >> Share

    November 2021
  128. NATHAN AS, Manandhar P, Wojdyla D, Nelson A, et al
    Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.
    J Am Coll Cardiol. 2021;78:2213-2217.
    >> Share

  129. GIRI J, Fanaroff AC
    1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
    J Am Coll Cardiol. 2021;78:2073-2075.
    >> Share

  130. HARRIS KM, Mena-Hurtado C, Arham A, Burg MM, et al
    Increasing Prevalence of Critical Limb Ischemia Hospitalizations With Distinct Mental Health Burden Among Younger Adults.
    J Am Coll Cardiol. 2021;78:2126-2128.
    >> Share

  131. VALGIMIGLI M, Cao D, Angiolillo DJ, Bangalore S, et al
    Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
    J Am Coll Cardiol. 2021;78:2060-2072.
    >> Share

  132. PARIKH PB
    Dual Antiplatelet Duration After DES: Is it Time to Say Goodbye to 1-Year DAPT?
    J Am Coll Cardiol. 2021;78:1987-1989.
    >> Share

  133. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
    Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
    J Am Coll Cardiol. 2021;78:1990-2000.
    >> Share

  134. RIOUFOL G, Derimay F, Roubille F, Perret T, et al
    Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
    J Am Coll Cardiol. 2021;78:1875-1885.
    >> Share

  135. ZELLER T, Bohme T
    Antiproliferative Device Coatings: Efficacy Without Adverse Drug Effect?
    J Am Coll Cardiol. 2021;78:1779-1781.
    >> Share

  136. HESS CN, Patel MR, Bauersachs RM, Anand SS, et al
    Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
    J Am Coll Cardiol. 2021;78:1768-1778.
    >> Share

    October 2021
  137. METKUS TS, Grant MC, Zwischenberger B, Higgins R, et al
    Reply: When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e139-e140.
    >> Share

  138. ZHAN Y, Brovman EY, Cobey F
    When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e137.
    >> Share

  139. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
    Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:1550-1563.
    >> Share

  140. AN KR, de Mestral C, Tam DY, Qiu F, et al
    Surveillance Imaging Following Acute Type A Aortic Dissection.
    J Am Coll Cardiol. 2021 Oct 5. pii: S0735-1097(21)06218.
    >> Share

    September 2021
  141. GUO MH, Vo TX, Horsthuis K, Rahmouni K, et al
    Durability of Minimally Invasive Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2021;78:1390-1391.
    >> Share

  142. KASTRATI A, Coughlan JJ, Ndrepepa G
    Primary PCI, Late Presenting STEMI, and the Limits of Time.
    J Am Coll Cardiol. 2021;78:1306-1308.
    >> Share

  143. BOUISSET F, Gerbaud E, Bataille V, Coste P, et al
    Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.
    J Am Coll Cardiol. 2021;78:1291-1305.
    >> Share

  144. SQUIERS JJ, DiMaio JM
    SYNTAX Score II 2020: A Remake Worth the Price of Admission?
    J Am Coll Cardiol. 2021;78:1239-1241.
    >> Share

  145. HARA H, Shiomi H, van Klaveren D, Kent DM, et al
    External Validation of the SYNTAX Score II 2020.
    J Am Coll Cardiol. 2021;78:1227-1238.
    >> Share

    August 2021
  146. WU EB, Brilakis ES, Mashayekhi K, Tsuchikane E, et al
    Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:840-853.
    >> Share

  147. HSIA J, Szarek M, Anand S, Patel MR, et al
    Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021;78:757-759.
    >> Share

  148. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
    Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
    J Am Coll Cardiol. 2021;78:468-477.
    >> Share

    July 2021
  149. SERRUYS PW, Ono M, Garg S, Hara H, et al
    Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
    J Am Coll Cardiol. 2021;78:384-407.
    >> Share

  150. BRENER SJ
    Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.
    J Am Coll Cardiol. 2021;78:230-233.
    >> Share

  151. SONNY A, Joseph L
    Improving CABG Mortality Further: Striving Toward Perfection.
    J Am Coll Cardiol. 2021;78:123-125.
    >> Share

  152. DOENST T, Bonow RO, Bhatt DL, Falk V, et al
    Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:180-188.
    >> Share

  153. BODEN WE, Gersh BJ
    Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy.
    J Am Coll Cardiol. 2021;78:39-41.
    >> Share

  154. KAWASHIMA H, Serruys PW, Ono M, Hara H, et al
    Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    J Am Coll Cardiol. 2021;78:27-38.
    >> Share

    June 2021
  155. ZALEWSKI PD, Tvorogova Z, Abdo A, Wawer AA, et al
    Harvesting Endothelial Cells During Routine Invasive Coronary Procedures.
    J Am Coll Cardiol. 2021;77:3136-3138.
    >> Share

  156. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
    Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:2872-2873.
    >> Share

  157. LI X, Ni S
    Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
    J Am Coll Cardiol. 2021;77:2872.
    >> Share

  158. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
    Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
    J Am Coll Cardiol. 2021;77:2871-2872.
    >> Share

  159. HESS CN, Fu JW, Gundrum J, Allen LaPointe NM, et al
    Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
    J Am Coll Cardiol. 2021;77:2867-2869.
    >> Share

  160. HIRA RS
    Revascularizing Complex CAD in Elderly Patients: The Coming-of-Age Story of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021;77:2774-2776.
    >> Share

  161. ONO M, Serruys PW, Hara H, Kawashima H, et al
    10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:2761-2773.
    >> Share

    May 2021
  162. FOGEL MA
    The Fontan: "Straining" to Understand That "The Bigger They Come, The Harder They Fall".
    J Am Coll Cardiol. 2021;77:2490-2493.
    >> Share

  163. MEYER SL, St Clair N, Powell AJ, Geva T, et al
    Integrated Clinical and Magnetic Resonance Imaging Assessments Late After Fontan Operation.
    J Am Coll Cardiol. 2021;77:2480-2489.
    >> Share

  164. ALVAREZ-FUENTE M, Ayala A, Garrido-Lestache E, Bermudez-Canete R, et al
    Long-Term Complications After Aortic Coarctation Stenting.
    J Am Coll Cardiol. 2021;77:2448-2450.
    >> Share

  165. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    >> Share

  166. MARLEVI D, Edelman ER
    Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2413-2431.
    >> Share

  167. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
    Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    J Am Coll Cardiol. 2021;77:2366-2377.
    >> Share

  168. BAUERSACHS RM, Szarek M, Brodmann M, Gudz I, et al
    Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021 May 7. pii: S0735-1097(21)05016.
    >> Share

  169. VINCIGUERRA M, Spadaccio C, Tennyson C, Karuppannan M, et al
    Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2236-2253.
    >> Share

  170. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
    ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2021;77:2187-2199.
    >> Share

    April 2021
  171. METKUS TS, Thibault D, Grant MC, Badhwar V, et al
    Utilization and outcomes of transesophageal echocardiography in 1.3 million CABG procedures.
    J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04930.
    >> Share

  172. CASTRO-DOMINGUEZ YS, Wang Y, Minges KE, McNamara RL, et al
    Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04934.
    >> Share

  173. GARCIA S, Dehghani P, Grines C, Davidson L, et al
    Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
    J Am Coll Cardiol. 2021;77:1994-2003.
    >> Share

  174. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
    Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
    J Am Coll Cardiol. 2021;77:2156-2157.
    >> Share

  175. TANG GHL, Tadros RO
    Endovascular Aortic Repair in Nonagenarians: Select Well and Time Appropriately.
    J Am Coll Cardiol. 2021;77:1900-1902.
    >> Share

  176. PRENDES CF, Dayama A, Panneton JM, Stana J, et al
    Endovascular Aortic Repair in Nonagenarian Patients.
    J Am Coll Cardiol. 2021;77:1891-1899.
    >> Share

  177. CHO KH, Han X, Ahn JH, Hyun DY, et al
    Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1859-1870.
    >> Share

  178. RIDKER PM
    Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.
    J Am Coll Cardiol. 2021;77:1856-1858.
    >> Share

  179. BROCH K, Anstensrud AK, Woxholt S, Sharma K, et al
    Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1845-1855.
    >> Share

  180. PERICAS JM, Llopis J, Jimenez-Exposito MJ, Kourany WM, et al
    Infective Endocarditis in Patients on Chronic Hemodialysis.
    J Am Coll Cardiol. 2021;77:1629-1640.
    >> Share

    March 2021
  181. EGBE AC, Borlaug BA
    Reply: Abnormal Pulmonary Vascular Reserve in Fontan: Pulmonary Vascular Disease Versus Diastolic Dysfunction.
    J Am Coll Cardiol. 2021;77:1596-1597.
    >> Share

  182. CEDARS A, Opotowsky A, Tedford RJ, Burkhoff D, et al
    Resist Neglecting Diastolic Dysfunction in Fontan Physiology.
    J Am Coll Cardiol. 2021;77:1595-1596.
    >> Share

  183. LATUS H, Apitz C
    Exercise-Induced Pulmonary Hypertension: The Final Answer to Characterize Pulmonary Vascular Disease in Fontan Patients?
    J Am Coll Cardiol. 2021;77:1594-1595.
    >> Share

  184. SABA PS, Parodi G, Ganau A
    From Risk Factors to Clinical Disease: New Opportunities and Challenges for Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2021;77:1436-1438.
    >> Share

  185. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
    TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
    J Am Coll Cardiol. 2021;77:1481-1483.
    >> Share

  186. LLANOS-CHEA F, Jelani QU, Trejo-Paredes C, Curtis JP, et al
    Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
    J Am Coll Cardiol. 2021;77:1374-1375.
    >> Share

  187. NAKASHIMA CAK, Dallan LAO, Lisboa LAF, Jatene FB, et al
    Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
    J Am Coll Cardiol. 2021;77:1277-1286.
    >> Share

  188. CUTLIP DE
    Standing the Test of Time: A Device and Patient Perspective.
    J Am Coll Cardiol. 2021;77:1179-1181.
    >> Share

    February 2021
  189. MCCARTHY CP, Kolte D, Kennedy KF, Vaduganathan M, et al
    Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:848-857.
    >> Share

  190. KRAWISZ AK, Rosenfield K, White CJ, Jaff MR, et al
    Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.
    J Am Coll Cardiol. 2021;77:835-844.
    >> Share

  191. MOSES JW, Prasad M
    Are All Total Occlusions Created Equal?: Striving for Complete Revascularization While Differentiating Apples From Oranges.
    J Am Coll Cardiol. 2021;77:541-543.
    >> Share

  192. KAWASHIMA H, Takahashi K, Ono M, Hara H, et al
    Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
    J Am Coll Cardiol. 2021;77:529-540.
    >> Share

  193. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
    Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
    J Am Coll Cardiol. 2021;77:345-356.
    >> Share

    January 2021
  194. OHMAN EM, Nanna MG
    Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
    J Am Coll Cardiol. 2021;77:268-270.
    >> Share

  195. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
    Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
    J Am Coll Cardiol. 2021;77:229-239.
    >> Share

  196. KOCHAR A, Varshney AS, Wang DE
    Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete?
    J Am Coll Cardiol. 2021;77:156-158.
    >> Share

  197. BARTHELEMY O, Rouanet S, Brugier D, Vignolles N, et al
    Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:144-155.
    >> Share

  198. LAWTON JS
    Why Not Give All Patients the Opportunity to Have the Benefits of BITA Grafting?
    J Am Coll Cardiol. 2021;77:27-28.
    >> Share

  199. GOLDSTEIN BH, Kreutzer J
    Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:80-96.
    >> Share

  200. WANG H, Zhang Y, Xin F, Jiang H, et al
    Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:57-67.
    >> Share

  201. GAUDINO M, Di Franco A, Flather M, Gerry S, et al
    Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.
    J Am Coll Cardiol. 2021;77:18-26.
    >> Share

    December 2020
  202. RAO SV, Vidovich MI, Gilchrist IC, Gulati R, et al
    2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2020 Dec 28. pii: S0735-1097(20)37778.
    >> Share

    November 2020
  203. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
    2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016